← Eichor
Condition: Duration Of The Second Stage Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Duration Of The Second Stage

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pushing Using Real-time Sonographic Ultrasound Education
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07000240
Use of Lubricant Gel to Shorten the Second Stage of Labor During Vaginal Delivery
NA · 1 location(s) · Universidad Nacional Autonoma de Honduras · NCT07428317
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
Phase N/A · 1 location(s) · Xijing Hospital · NCT06613165
Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)
Phase 3 · 1 location(s) · Hallym University Medical Center · NCT04787354
Use of Papaverine to Shorten the Second Stage/Duration of Labor in Pregnant Women After Cervical Ripening by Double-ball
NA · 1 location(s) · Hillel Yaffe Medical Center · NCT07237880
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Se
Phase 1/Phase 2 · 18 location(s) · Sanofi · NCT07215234
Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
Phase 3 · 2 location(s) · Hunan Province Tumor Hospital · NCT07251582
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.